FDA NDC Directory · JSON-LD · Markdown

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release

NDC 42858-055 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE

Generic nameDEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE
Labeler / ManufacturerRhodes Pharmaceuticals LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA210651
Dosage form / routeCAPSULE, EXTENDED RELEASE · ORAL
Active ingredientsAMPHETAMINE ASPARTATE MONOHYDRATE (1.25 mg/1)
AMPHETAMINE SULFATE (1.25 mg/1)
DEXTROAMPHETAMINE SACCHARATE (1.25 mg/1)
DEXTROAMPHETAMINE SULFATE (1.25 mg/1)
Marketing started20190822
Package count1

External sources

Source: openFDA. Public-domain (CC0).